Financials

Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
190.53
Price to sales ratio
0.01

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
772
ALGN
Align Technology, Inc. - Common Stock
180.59 USD+0.64%-4.76%+1.52%-4.94%12.93 B USD
831
BAX
Baxter International Inc. Common Stock
22.59 USD-0.13%-1.91%+7.01%-21.43%11.67 B USD
1035
ATR
AptarGroup, Inc. Common Stock
124.90 USD-0.51%-1.51%+5.72%-20.69%7.97 B USD
1211
TFX
Teleflex Incorporated Common Stock
136.21 USD+0.35%+0.54%+4.95%+17.02%6.03 B USD

Frequently asked questions about Repligen Corporation - Common Stock

What is the Repligen Corporation - Common Stock stock price today?

The current price of Repligen Corporation - Common Stock (RGEN) is 144.88. Over the past 24 hours, the stock has changed by +0.44%. Follow the RGEN chart for real-time price dynamics.

What is the stock ticker of Repligen Corporation - Common Stock?

Repligen Corporation - Common Stock trades under the ticker RGEN. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Repligen Corporation - Common Stock stock going up?

RGEN has changed by +0.21% over the last week, +8.35% over the last month, and -12.56% over the last year. Review the chart to see whether the current move is part of a broader trend.

What was Repligen Corporation - Common Stock net income for the last quarter?

Repligen Corporation - Common Stock reported net income of 8.33 M for the last quarter. The previous quarter showed 13.29 M, which means net income changed by -37.28%.

How many employees does Repligen Corporation - Common Stock have?

As of the latest available data, Repligen Corporation - Common Stock has 2 000 employees. Workforce size can provide additional context about the company's scale and operations.

What is Repligen Corporation - Common Stock EBITDA?

Repligen Corporation - Common Stock EBITDA is 30.11 M, and its EBITDA margin is 15.5%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Repligen Corporation - Common Stock stock?

You can buy Repligen Corporation - Common Stock (RGEN) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Repligen Corporation - Common Stock stock?

Investing in Repligen Corporation - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the RGEN chart and related analysis on metatrader.com as part of your research.

Repligen Corporation - Common Stock

Repligen Corporation is a global life sciences company devoted to the development and commercialization of innovative bioprocessing technologies and systems that enable efficiencies in the process of manufacturing biological drugs. The company is based in Waltham, Massachusetts, and was incorporated in Delaware in 1981. A public company, Repligen is listed on the NASDAQ exchange under the symbol RGEN. As of 2025, Repligen employs over 1,900 employees globally and serves primarily biopharmaceutical drug developers and contract development and manufacturing organizations worldwide.

News